Furthermore, the immune cell counts in tumor‐border slices were significantly higher compared with non‐tumor tissue (CD45: 8.3‐fold; CD3+/CD8+: sixfold; and CD3+/CD8−: sevenfold) as well as tumor‐central tissue (Figure 1C). The gene discussed is PTPRC; the disease is neoplasm.